Using Sensors to Measure Drug Concentrations in Exhaled Breath

Nadav Goldental

Status: Unknown

Conditions: Mental Disorder

Study type: Observational

Funder types: Other

Identifiers

NCT04071145

6419-19-SMC

Details and patient eligibility

About

The use of blood tests to measure drug concentrations in psychiatric patients is often a crucial part of monitoring and evaluating the course of treatment. Such tests are commonly conducted as part of official protocols, and patients are often tested on a weekly basis.

The current study aims to examine the possibility of using a novel, non-invasive device to measure drug concentrations in exhaled breath as an alternative to blood tests. The device, SniffPhone, uses sensors to detect and measure volatile organic compounds (VOCs) in exhaled breath, and features a small and portable design. Sniff Phone has been previously approved for use in clinical trials and has been used successfully to screen for particular types of cancer and other diseases.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Proper ability to give informed consent
• Psychiatric patients undergoing treatment at Sheba Medical Center
• Patients with treatment plans that require therapeutic drug monitoring

Exclusion criteria

• Involuntary psychiatric hospitalization
• Pregnancy